Search results
Results From The WOW.Com Content Network
Expenditures by federal and provincial organizations on scientific research and development accounted for about 10% of all such spending in Canada in 2006. These organizations are active in natural and social science research, engineering research, industrial research and medical research.
BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. [1] It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions ...
Biotechnology/Chartered Professional Accountancy Co-op (Biotech/CPA): This program is offered jointly with the Faculty of Science. Students in the Biotech/CPA program take science courses along with the accounting and finance courses. Biotech/CPA students have little flexibility in their degree, and in some terms, are required to take extra ...
Sanofi Biogenius Canada was founded in 1992 by Sanofi Pasteur to engage younger students in biotechnology education. [2]The program is managed by Partners in Research, on behalf of Sanofi Pasteur and Sanofi Canada, and in partnership with science outreach and biotechnology industry organizations across Canada.
Universities in Canada are established and operate under provincial and territorial government charters or are directed by First Nations bands [a] or by federal legislation. [b] Most public universities in the country are members of Universities Canada, a non-profit organization. The title "university" is protected under federal regulation.
Medicago Inc. was a Canadian biotechnology company focused on the discovery, development, and commercialization of virus-like particles using plants as bioreactors to produce proteins, candidate vaccines, and medications.
The positive results [5] of this first study led to the rapid and continuous expansion of Oncolytics’ clinical trial program, with phase 2 studies beginning in Canada in 2001, U.S. and subsequent cross-border studies beginning in 2002, and enrollment in a multi-site phase 3 trial beginning in 2010. [6]
In 2006, total spending on scientific and industrial research in Canada amounted to C$28.067 billion or about 2 percent of GDP. In 2006, Canadian universities spent C$10.890 billion on research and development, representing about 40 percent of all R&D spending in Canada and about .66 percent of Canada's GDP.